(Q45067817)

9 December 2017

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention (English)

1 reference

9 December 2017

8

Elisabetta Bugianesi

1 reference

9 December 2017

6

Mohammed Eslam

1 reference

9 December 2017

Zobair Younossi

1

1 reference

9 December 2017

Quentin M Anstee

2

1 reference

9 December 2017

Milena Marietti

3

1 reference

9 December 2017

Timothy Hardy

4

1 reference

9 December 2017

Linda Henry

5

1 reference

9 December 2017

Jacob George

7

1 reference

9 December 2017

language of work or name

English

0 references

publication date

20 September 2017

1 reference

Nature Reviews Gastroenterology & Hepatology

9 December 2017

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2017.109

9 December 2017

0 references

cites work

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Gender and racial differences in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Racial differences in nonalcoholic fatty liver disease in the U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Global Epidemiology of Nonalcoholic Fatty Liver Disease and Perspectives on US Minority Populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Nonalcoholic Fatty Liver Disease in Latinos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Acculturation and Nonalcoholic Fatty Liver Disease Risk Among Hispanics of Mexican Origin: Findings From the National Health and Nutrition Examination Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Ethnicity and nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

NAFLD prevalence differs among hispanic subgroups: the Multi-Ethnic Study of Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence of suspected nonalcoholic fatty liver disease in Hispanic/Latino individuals differs by heritage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Liver fat in the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Incidence and natural course of fatty liver in the general population: the Dionysos study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Steatosis and steatohepatitis in postmortem material from Northwestern Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Clinical correlation of nonalcoholic fatty liver disease in a Chinese taxi drivers population in Taiwan: Experience at a teaching hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Nonalcoholic fatty liver disease in lean individuals in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Characteristics of metabolically obese normal-weight (MONW) subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Body mass index in school-aged children and the risk of routinely diagnosed non-alcoholic fatty liver disease in adulthood: a prospective study based on the Copenhagen School Health Records Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Body mass index in childhood and adult risk of primary liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Childhood predictors of adult fatty liver. The Cardiovascular Risk in Young Finns Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Heritability of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

21 January 2018

The genetics of NAFLD.

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Multigenerational epigenetic adaptation of the hepatic wound-healing response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Nutritional assessments of patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

The role of diet and nutrient composition in nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

The benefits of exercise for patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Trends in outpatient resource utilizations and outcomes for Medicare beneficiaries with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Liver biopsy findings from healthy potential living liver donors: Reasons for disqualification, silent diseases and correlation with liver injury tests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Prevalence of fatty liver disease and its risk factors in the population of South China

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Non-alcoholic fatty liver disease (NAFLD) in the Western Cape: a descriptive analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Non alcoholic fatty liver disease (NAFLD) in a Sudanese population: What is the prevalence and risk factors?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

Impact of race/ethnicity on the relationship between visceral fat and inflammatory biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2017.109

7 January 2021

inferred from DOI database lookup

Lean non-alcoholic fatty liver disease (Lean-NAFLD): a major cause of cryptogenic liver disease.

1 reference

12 December 2020

The prevalence of nonalcoholic fatty liver disease in the Americas

1 reference

12 December 2020

Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community

1 reference

12 December 2020

Survey of health status, nutrition and geography of food selection of chronic liver disease patients.

1 reference

12 December 2020

Prevalence of non-alcoholic fatty liver disease: population based study.

1 reference

12 December 2020

Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey.

1 reference

12 December 2020

Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients.

1 reference

12 December 2020

Note of appreciation/ Note de reconnaissance

1 reference

12 December 2020

Non-alcoholic fatty liver disease may develop in individuals with normal body mass index

1 reference

12 December 2020

Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China.

1 reference

12 December 2020

Non-alcoholic fatty liver disease and metabolic syndrome in Brazilian middle-aged and older adults

1 reference

12 December 2020

Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.

1 reference

12 December 2020

10.1038/NRGASTRO.2017.109

Identifiers

DOI

1 reference

Dimensions Publication ID

9 December 2017

0 references

1 reference